Skip to content

Lidocaine And Neuromonitoring in Thyroid Surgery

Intravenous Or Topical Lidocaine And Neuromonitoring in Thyroid Surgery (IOLANT Study)

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04574947
Enrollment
110
Registered
2020-10-05
Start date
2021-01-25
Completion date
2023-12-31
Last updated
2024-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Neoplasm, Parathyroid Neoplasms, Anesthesia

Brief summary

The aim of this study is to test the hypothesis that the quality of recovery with topical lidocaine is better than placebo.

Detailed description

The use of neuromonitoring in thyroid surgery imposes a number of special demands for anaesthetic management. Such demands include avoiding muscle relaxation and local anaesthesia. Maintaining a balance between the risk of awakening during surgery and excessively deep anaesthesia in fast track surgery is an important task for the anaesthesiologist. Mild anaesthesia in the absence of muscle relaxation increases the risk of developing laryngeal reflexes, coughing during surgery, while excessively deep anaesthesia slows down recovery after surgery and increases the risk of arterial hypotension. The frequency and duration of arterial hypotension, as well as the depth of anesthesia assessed by the Bispectral index, are independent risk factors for postoperative cardiovascular complications and long-term mortality. On the other hand, coughing in response to irritation of the endotracheal tube during recovery from anesthesia is recognized as a risk factor for respiratory and cardiovascular complications, as well as postoperative wound insufficiency. Optimization the anesthesia by intravenous infusion of lidocaine can improve anesthesia controllability, hemodynamic stability and overall anesthesia recovery rates. Local use of lidocaine, including filling the endotracheal tube cuff with its alkalinized solution, has also been shown to be effective in reducing the frequency of laryngeal reflexes upon awakening after surgery of varying duration. However, the efficacy and safety of local use of lidocaine under neuromonitoring conditions has not been studied. Despite recommendations to avoid the local use of lidocaine for tracheal intubation, there is evidence of the safety of this technique in the absence of a negative impact on the quality of neuromonitoring. The purpose of this study is to test the hypothesis that the quality of recovery with topical lidocaine is better than placebo. At the same time, the investigators assume that recovery after surgery will be comparable with both local and intravenous use. Intergroup differences in arterial hypotension, depth of anesthesia and intraoperative neuromonitoring parameters will also be investigated.

Interventions

Lidocaine IV 1.5 mg / kg BMI will be administered during induction into anaesthesia followed by infusion at a dose of 1.5 mg / kg / h until the end of the surgery.

DRUGIntravenous placebo

During induction and maintenance of anaesthesia, 0.9% sodium chloride solution will be injected intravenously at a rate equivalent to lidocaine solution.

PROCEDUREIntra-cuff lidocaine

The lidocaine solution will be applied to the intubation tube and the cuff will be filled with an alkalinised lidocaine solution.

PROCEDUREIntra-cuff placebo

The intubation tube will be lubricated 0.9% sodium chloride, the tube cuff will be filled with 0.9% sodium chloride solution.

Sponsors

Saint Petersburg State University, Russia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Planned thyroid surgery * Age\> 45 years * Signed informed consent to participate in the study

Exclusion criteria

* Emergency surgery * Redo surgery * Contraindications for lidocaine use * Pregnancy * Enrolment to another randomised clinical trial within the last 30 days

Design outcomes

Primary

MeasureTime frameDescription
Quality of recovery 40 questionnaireFirst postoperative dayMinimum and maximum values: 40 and 200, where higher scores mean a better outcomes

Secondary

MeasureTime frameDescription
Hypotension durationIntraoperativeCumulative duration of arterial hypotension (SBP \<60 mm Hg) expressed in minutes
Cough rateIn the operating room and during awakening.Frequency of laryngeal reflexes
Minimal bispectral indexDuring surgeryMinimal observed intraoperative bispectral index value. Values less than 40 mean a worse outcomes.
Hypotension incidenceIntraoperativeIncidence of arterial hypotension (SBP \<60 mm Hg)
AmplitudeDuring surgeryAmplitude of electromyographic potential during neuromonitoring of recurrent nerve
LatencyDuring surgeryLatency of electromyographic potential during neuromonitoring of recurrent nerve
Bispectral index less then 40During surgeryCumulative duration of bispectral index less than 40. Values less than 40 mean a worse outcomes.

Countries

Russia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026